Protein kinase B (PKB)
Protein kinase B (PKB), also known as AKT, is a serine/threonine kinase and the central effector of the phosphoinositide 3-kinase (Phosphatidylinositol 3-kinase (PI3K))/AKT/mTOR pathway.
Protein kinase B (PKB), also known as AKT, is a serine/threonine kinase and the central effector of the phosphoinositide 3-kinase (Phosphatidylinositol 3-kinase (PI3K))/AKT/mTOR pathway. Activation is a two-step, membrane-dependent event: PI3K generates PIP3, which recruits PKB through its pleckstrin homology domain, whereupon PDK1 phosphorylates Thr308 in the activation loop and mTORC2 phosphorylates Ser473 to complete activation. The phosphatase PTEN opposes the first step by removing the 3-phosphate from PIP3, and its loss leaves the kinase constitutively active. Once active, PKB phosphorylates substrates governing survival, proliferation, growth and metabolism — glycogen synthase kinase 3β (GSK-3β), FOXO transcription factors, the pro-apoptotic protein BAD, and the TSC complex upstream of the mechanistic target of rapamycin (Mtor). Humans express three isoforms with distinct emphases rather than interchangeable roles: AKT1 in growth and survival, AKT2 in insulin-responsive glucose uptake in muscle and fat, and AKT3 predominantly in brain. Because its phosphorylation state reports on PI3K pathway activity downstream of multiple inputs — signaling through the EGFR, fibroblast growth factor receptors and other receptor tyrosine kinases — phosphorylated AKT (p-AKT) is among the most commonly used readouts of pathway activation in biomedical research.
The axis is one of the most frequently deregulated in human cancer, usually through PIK3CA mutation or PTEN loss rather than through AKT itself, though the recurrent Akt1 E17K substitution activates the kinase directly by driving membrane localization. Work in hepatocellular carcinoma and breast cancer implicates PTEN/AKT and TP53-linked signaling in proliferation, cell-cycle progression and chemotherapy resistance, and the pathway's crosstalk with MYC and NF-κB ties it to transcriptional and inflammatory programs. ATP-competitive and allosteric AKT inhibitors have reached the clinic, with targeted degraders in development; because the same kinase carries insulin's signal, hyperglycemia is a mechanism-based class toxicity rather than an incidental one.
Beyond oncology, PKB underlies insulin-responsive glucose and lipid handling and is examined in obesity, type 2 diabetes, sepsis-associated liver injury and metabolic dysfunction–associated steatotic liver disease, often alongside AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptors. AKT/GSK-3β signaling is studied in neurodegeneration, where it regulates tau phosphorylation and neuronal apoptosis, and pathway activation contributes to angiogenesis, epithelial–mesenchymal transition and tissue repair including skin wound healing. Akt1 recurs as a hub in network-pharmacology analyses of natural products such as quercetin and kaempferol, a literature whose in vivo relevance is largely unsettled.
Where the papers sit
36 papers from the last 6 months study Protein kinase B (PKB) directly · updated from PubMed 16 Nov 2026
Study type 1 clinical trial · 4 human data · 28 preclinical · 3 unclassified
Themes 4 themes · 1 new direction
-
PI3K/Akt Disease Modulation
PI3K/Akt signaling is being treated as a context-dependent control point for tissue repair, inflammation, metabolism, and cancer growth. Activating the pathway supports wound healing and protection from ischemic, cardiac, hepatic, and neuronal injury, often through Nrf2, NRG-1/ErbB2, or mPTP mechanisms. In hepatocellular carcinoma and fibrosis, studies instead pursue pathway suppression or rewiring to restrain proliferation, macrophage activation, and metastatic behavior. Natural products dominate the evidence, leaving target specificity and translation beyond preclinical models unresolved.
14 papers · 38.9%
-
AKT/mTOR Disease Signaling
AKT/mTOR signaling is being positioned as a therapeutic link between breast-cancer growth, apoptosis, metastasis, and treatment resistance. Exosomal p-AKT and copy-number gains support pathway activation as a resistance and prognostic marker, while capivasertib is being tested with durvalumab and paclitaxel in triple-negative disease. Other work extends AKT/mTOR modulation to neuronal injury, sepsis, and mesothelioma. The cluster favors pathway-directed intervention but remains split between inhibition in cancer and restoration of survival signaling in tissue injury.
8 papers · 22.2%
-
Inflammation and Metabolic Disease
Inflammatory cytokine networks, especially TNF-α and IL-6, are being linked to metabolic, reproductive, skeletal, hepatic, and renal disease. Network pharmacology and phytochemical profiling repeatedly nominate multi-target compounds that dampen cytokine signaling while restoring antioxidant or metabolic balance. Gut-microbiota effects in polycystic ovary syndrome and immune-metabolic changes in sepsis-associated kidney injury broaden the focus beyond a single organ. Most support remains mechanistic or preclinical, so the clinical value of these compounds and their targets is still open.
8 papers · 22.2%
-
Phytochemical Target Discovery
Phytochemical screening is being used to prioritize compounds with anticancer, antiviral, and anti-inflammatory potential. AKT1 and EGFR recur as predicted targets, alongside broader protein-interaction and pathway networks. Molecular docking and dynamics provide mechanistic hypotheses for compounds from medicinal plants and traditional formulas. Experimental validation of binding, selectivity, and activity remains the main open step.
6 papers · 16.7%
Protein kinase B (PKB) becomes a transferable resistance factor between breast-cancer cells
The breast-cancer model of doxorubicin resistance studied exosomal transfer of phosphorylated AKT and found that p-AKT-containing exosomes propagate chemoresistance between cells and predict poor prognosis, rather than PKB functioning only as an intracellular signaling mediator or downstream biomarker. This makes extracellular vesicular transfer of activated PKB a mechanism of treatment-resistance transmission and a possible therapeutic target. 42417926Jul
Papers
The 36 papers from the last 6 months that study Protein kinase B (PKB) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
PI3K/Akt Disease Modulation (14)
- Ginkgolide A alleviated liver fibrosis by modulating PI3K/AKT/NF-κB signaling to inhibit M1 macrophage polarization and macrophage-HSC crosstalk. International immunopharmacology · 27 Aug 2026 PMID 42659933
- Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
- Integrated GNPS Molecular Networking and Network Pharmacology Uncover Methylophiopogonanone B as a Novel Anti-Inflammatory Agent From Polygonatum cyrtonema Hua Targeting the SRC-PI3K-Akt Pathway. Biomedical chromatography : BMC · 22 Jul 2026 PMID 42484235
- ADSC-Exo-bFGF promotes skin wound healing and correlates with the PI3K/AKT signaling pathway activation. Journal of molecular histology · 16 Jul 2026 PMID 42461467
- Cistanoside A decreases Tau hyperphosphorylation and neuronal apoptosis through the AKT/GSK3β pathway in okadaic acid-induced in vivo and in vitro models of Alzheimer's disease. Molecular biology reports · 9 Jul 2026 PMID 42423799
- RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1. Journal of medicinal chemistry · 8 Jul 2026 PMID 42417401
- CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway. Human cell · 1 Jul 2026 PMID 42384246
- Targeted activation of PPARG or AKT1 alleviates liver injury in mice with type 2 diabetes and sepsis by modulating inflammatory and metabolic pathways. Annals of medicine · 19 Jun 2026 PMID 42319089
- Dimethyl fumarate attenuates post-infarct myocardial injury and is associated with modulation of the NRG-1/ErbB2/Akt pathway and reduction of oxidative stress. European journal of pharmacology · 2 Jun 2026 PMID 42229738
- Prenylated flavonoids from Sophora flavescens (Kushen) inhibit hepatocellular carcinoma growth by suppressing the Akt/MDM2/p53 pathway to activate mitochondrial apoptosis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 29 May 2026 PMID 42214227
- Ergothioneine exerts neuroprotection in experimental ischemic stroke via activation of PI3K/Akt/Nrf2 pathway. Neuroreport · 29 May 2026 PMID 42214028
- Cilostazol inhibits TGF-α-induced migration of hepatocellular carcinoma cells by activating PPARγ. Biochemical and biophysical research communications · 26 May 2026 PMID 42190601
- Nuciferine alleviates cerebral ischemia-reperfusion injury by inhibiting mPTP opening via activating the phosphatidylinositol 3-kinase/protein kinase B/glycogen synthase kinase 3 beta pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology · 22 May 2026 PMID 42172986
- PRXL2B facilitates the progression of hepatocellular carcinoma and the therapeutic efficacy of oncolytic adenovirus H101 through the PI3K/AKT/PD-L1 axis. Bioscience trends · 20 May 2026 PMID 42161529
AKT/mTOR Disease Signaling (8)
- Metabolic-epigenetic rewiring of CCR5hi monocytes sustains long-term trained immunity against lethal sepsis. Science advances · 21 Aug 2026 PMID 42627899
- Artemisinin liposomes regulates breast cancer metastasis and apoptosis through TIGIT/CD155 signal axis. Apoptosis : an international journal on programmed cell death · 27 Jul 2026 PMID 42507162
- Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer. Molecular biology reports · 8 Jul 2026 PMID 42417926
- A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
- Genome-wide copy number analysis identifies AKT as a novel therapeutic target in pleural mesothelioma. Lung cancer (Amsterdam, Netherlands) · 30 Jun 2026 PMID 42378954
- Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research · 26 May 2026 PMID 42189888
- Butyrate Regulates the Blood-Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer's Disease Amyloid-Beta Peptides. Molecular pharmaceutics · 21 May 2026 PMID 42166642
- Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
Inflammation and Metabolic Disease (8)
- Integrating network toxicology and transcriptomics to identify CXCL8, EGFR, PTPRC, MYC, and AKT1 as key targets of microplastic-induced miscarriage. Medicine · 22 Aug 2026 PMID 42629697
- Network-based prioritization of sepsis-associated metabolites and in vivo validation of diosmetin in sepsis-associated acute kidney injury. Molecular biology reports · 21 Aug 2026 PMID 42627418
- Network pharmacology and molecular simulation study on the multi-target gene regulatory mechanism of Isatis indigotica against hepatic inflammation. PloS one · 13 Aug 2026 PMID 42594138
- Integrated UPLC-MS/MS profiling and network pharmacology-based analysis of the anti-hyperglycemic potential of Baihu Jia Renshen Decoction combined with Sanghuangporus vaninii extract in mice. Journal of molecular histology · 1 Aug 2026 PMID 42541619
- Phytochemical and anti-inflammatory profiling of Amomum maximum Roxb. Fruits reveal undescribed diarylheptanoids and labdane diterpenoids. Fitoterapia · 20 Jul 2026 PMID 42476423
- Network pharmacology-guided discovery of quercetin as an anti-osteoporotic agent from cyathulae radix with dual pro-osteogenic and antioxidant effects. Molecular biology reports · 20 Jul 2026 PMID 42474720
- Targeting the gut-ovarian axis: Scutellaria baicalensis improves polycystic ovary syndrome by modulating gut microbiota composition and inhibiting the LPS/TLR4/NF-κB signaling pathway. mSystems · 15 Jun 2026 PMID 42294648
- Luteolin-Loaded WPI/Pueraria lobata Amylopectin Composite Gel Improves Adipocyte Thermogenesis and Insulin Sensitivity. ACS applied bio materials · 12 Jun 2026 PMID 42283235
Phytochemical Target Discovery (6)
- In Silico Prioritization of Potential Protein Interactions for Glutathione-Responsive Abasic Site-Trapping Prodrugs in Non-Small Cell Lung Cancer. Journal of visualized experiments : JoVE · 30 Sept 2026 PMID 42813677
- Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer. Molecular biology reports · 12 Sept 2026 PMID 42730982
- A Principle-Guided Multistep Workflow for Screening Potential Quality Marker Candidates of Sanqi Shangyao Tablet Based on UHPLC-Q-Orbitrap MS, In Silico Screening, and In Vitro Validation. Biomedical chromatography : BMC · 15 Jul 2026 PMID 42453089
- Revealing the mechanism of heptamethoxyflavone against diabetic kidney disease: an integrated study combining network pharmacology, molecular docking and experimental validation. Biochemical and biophysical research communications · 13 Jul 2026 PMID 42442088
- Isobonducellin phytocompound from Artemisia annua L. plant exhibits anti-colorectal cancer activity via AKT1 regulation: an in-silico study. Computers in biology and medicine · 10 Jul 2026 PMID 42431013
- The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata. Antiviral research · 26 Jun 2026 PMID 42362061
By study type
Clinical trials (1)
- Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research · 26 May 2026 PMID 42189888
Human data, design not indexed (4)
- In Silico Prioritization of Potential Protein Interactions for Glutathione-Responsive Abasic Site-Trapping Prodrugs in Non-Small Cell Lung Cancer. Journal of visualized experiments : JoVE · 30 Sept 2026 PMID 42813677
- Integrating network toxicology and transcriptomics to identify CXCL8, EGFR, PTPRC, MYC, and AKT1 as key targets of microplastic-induced miscarriage. Medicine · 22 Aug 2026 PMID 42629697
- Network pharmacology and molecular simulation study on the multi-target gene regulatory mechanism of Isatis indigotica against hepatic inflammation. PloS one · 13 Aug 2026 PMID 42594138
- Isobonducellin phytocompound from Artemisia annua L. plant exhibits anti-colorectal cancer activity via AKT1 regulation: an in-silico study. Computers in biology and medicine · 10 Jul 2026 PMID 42431013
Preclinical: animal, cell and lab studies (28)
- Proteomic regulation of anti-proliferative and anti-migratory activity by potent phytochemicals from Pistacia integerrima J.L. Steward Ex Brandis via PI3K, AKT1, and KRAS for Lung Cancer. Molecular biology reports · 12 Sept 2026 PMID 42730982
- Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
- Metabolic-epigenetic rewiring of CCR5hi monocytes sustains long-term trained immunity against lethal sepsis. Science advances · 21 Aug 2026 PMID 42627899
- Network-based prioritization of sepsis-associated metabolites and in vivo validation of diosmetin in sepsis-associated acute kidney injury. Molecular biology reports · 21 Aug 2026 PMID 42627418
- Integrated UPLC-MS/MS profiling and network pharmacology-based analysis of the anti-hyperglycemic potential of Baihu Jia Renshen Decoction combined with Sanghuangporus vaninii extract in mice. Journal of molecular histology · 1 Aug 2026 PMID 42541619
- Artemisinin liposomes regulates breast cancer metastasis and apoptosis through TIGIT/CD155 signal axis. Apoptosis : an international journal on programmed cell death · 27 Jul 2026 PMID 42507162
- Integrated GNPS Molecular Networking and Network Pharmacology Uncover Methylophiopogonanone B as a Novel Anti-Inflammatory Agent From Polygonatum cyrtonema Hua Targeting the SRC-PI3K-Akt Pathway. Biomedical chromatography : BMC · 22 Jul 2026 PMID 42484235
- Phytochemical and anti-inflammatory profiling of Amomum maximum Roxb. Fruits reveal undescribed diarylheptanoids and labdane diterpenoids. Fitoterapia · 20 Jul 2026 PMID 42476423
- Network pharmacology-guided discovery of quercetin as an anti-osteoporotic agent from cyathulae radix with dual pro-osteogenic and antioxidant effects. Molecular biology reports · 20 Jul 2026 PMID 42474720
- ADSC-Exo-bFGF promotes skin wound healing and correlates with the PI3K/AKT signaling pathway activation. Journal of molecular histology · 16 Jul 2026 PMID 42461467
- A Principle-Guided Multistep Workflow for Screening Potential Quality Marker Candidates of Sanqi Shangyao Tablet Based on UHPLC-Q-Orbitrap MS, In Silico Screening, and In Vitro Validation. Biomedical chromatography : BMC · 15 Jul 2026 PMID 42453089
- Revealing the mechanism of heptamethoxyflavone against diabetic kidney disease: an integrated study combining network pharmacology, molecular docking and experimental validation. Biochemical and biophysical research communications · 13 Jul 2026 PMID 42442088
- Cistanoside A decreases Tau hyperphosphorylation and neuronal apoptosis through the AKT/GSK3β pathway in okadaic acid-induced in vivo and in vitro models of Alzheimer's disease. Molecular biology reports · 9 Jul 2026 PMID 42423799
- Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer. Molecular biology reports · 8 Jul 2026 PMID 42417926
- A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
- CNOT9 affects hepatocellular carcinoma proliferation and cell cycle through the PTEN/AKT/p53 signaling pathway. Human cell · 1 Jul 2026 PMID 42384246
- Genome-wide copy number analysis identifies AKT as a novel therapeutic target in pleural mesothelioma. Lung cancer (Amsterdam, Netherlands) · 30 Jun 2026 PMID 42378954
- The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata. Antiviral research · 26 Jun 2026 PMID 42362061
- Targeted activation of PPARG or AKT1 alleviates liver injury in mice with type 2 diabetes and sepsis by modulating inflammatory and metabolic pathways. Annals of medicine · 19 Jun 2026 PMID 42319089
- Targeting the gut-ovarian axis: Scutellaria baicalensis improves polycystic ovary syndrome by modulating gut microbiota composition and inhibiting the LPS/TLR4/NF-κB signaling pathway. mSystems · 15 Jun 2026 PMID 42294648
- Luteolin-Loaded WPI/Pueraria lobata Amylopectin Composite Gel Improves Adipocyte Thermogenesis and Insulin Sensitivity. ACS applied bio materials · 12 Jun 2026 PMID 42283235
- Dimethyl fumarate attenuates post-infarct myocardial injury and is associated with modulation of the NRG-1/ErbB2/Akt pathway and reduction of oxidative stress. European journal of pharmacology · 2 Jun 2026 PMID 42229738
- Prenylated flavonoids from Sophora flavescens (Kushen) inhibit hepatocellular carcinoma growth by suppressing the Akt/MDM2/p53 pathway to activate mitochondrial apoptosis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 29 May 2026 PMID 42214227
- Ergothioneine exerts neuroprotection in experimental ischemic stroke via activation of PI3K/Akt/Nrf2 pathway. Neuroreport · 29 May 2026 PMID 42214028
- Cilostazol inhibits TGF-α-induced migration of hepatocellular carcinoma cells by activating PPARγ. Biochemical and biophysical research communications · 26 May 2026 PMID 42190601
- Nuciferine alleviates cerebral ischemia-reperfusion injury by inhibiting mPTP opening via activating the phosphatidylinositol 3-kinase/protein kinase B/glycogen synthase kinase 3 beta pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology · 22 May 2026 PMID 42172986
- Butyrate Regulates the Blood-Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer's Disease Amyloid-Beta Peptides. Molecular pharmaceutics · 21 May 2026 PMID 42166642
- Platelet-rich plasma-primed bone marrow mesenchymal stem cell-derived exosomes inhibit neuronal apoptosis and autophagy, and promote nerve regeneration via the miR-29a-3p/PTEN/PI3K/Akt/mTOR axis after spinal cord injury. Journal of molecular histology · 21 May 2026 PMID 42165939
Unclassified: not yet indexed with MeSH (3)
- Ginkgolide A alleviated liver fibrosis by modulating PI3K/AKT/NF-κB signaling to inhibit M1 macrophage polarization and macrophage-HSC crosstalk. International immunopharmacology · 27 Aug 2026 PMID 42659933
- RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1. Journal of medicinal chemistry · 8 Jul 2026 PMID 42417401
- PRXL2B facilitates the progression of hepatocellular carcinoma and the therapeutic efficacy of oncolytic adenovirus H101 through the PI3K/AKT/PD-L1 axis. Bioscience trends · 20 May 2026 PMID 42161529
Written from 36 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-14 by GPT. Corrections: 2026-08-08 by GPT. Reviewed by a human editor on 2026-07-23. Drafted by language models from published abstracts; not medical advice.